Medical Declaration of Independence

When in the course of medical history it becomes apparent that certain entities and individuals with power and authority in the medical field fail to abide by the adage of “first do no harm,” necessity and prudence dictate that the time is nigh for patients and physicians, who have depended upon such medical entities and individuals for accurate and unbiased medical truths, to officially declare such medical entities and individuals as being harmful to the health and well-being of the patient community.  In this instance, such declaration is based upon the entities' and individuals' selfish and despicable actions – actions that are obviously contrary to the admonition of “first do no harm.” 

Therefore, let it be resolved that, on behalf of the worldwide Lyme disease/Borrelia-infected community, we solemnly declare independence from the following entities and individuals: 


Centers for Disease Control and Prevention (CDC)
Infectious Diseases Society of America (IDSA)
IDSA’s 2000 and 2006 Lyme Disease Practice Guideline Authors
American Academy of Neurology (AAN)
AAN’s 2007 Lyme Disease Practice Guideline Authors
National Institutes of Health (NIH)
Food and Drug Administration (FDA)
Kaiser Permanente
New York Medical College
Yale University

Authors of the Practice Guidelines for the Treatment of Lyme Disease (IDSA 2000) 

Gary P. Wormser
Robert B. Nadelman
Raymond J. Dattwyler
David T. Dennis
Eugene D. Shapiro
Allen C. Steere
Thomas J. Rush
Daniel W. Rahn
Patricia K. Coyle
David H. Persing
Durland Fish
Benjamin J. Luft 

Authors of The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA 2006) 

Gary P. Wormser
Raymond J. Dattwyler
Eugene D. Shapiro
John J. Halperin
Allen C. Steere
Mark S. Klempner
Peter J. Krause
Johan S. Bakken
Franc Strle
Gerold Stanek
Linda Bockenstedt
Durland Fish
J. Stephen Dumler
Robert B. Nadelman

Authors of Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review)  (AAN 2007)

J.J. Halperin, MD
E.D. Shapiro, MD
E. Logigian, MD
A.L. Belman, MD
L. Dotevall, MD
G.P. Wormser, MD
L. Krupp, MD
G. Gronseth, MD
C.T. Bever Jr., MD

Sponsors of the Second National Conference on Serologic Diagnosis of Lyme Disease, Dearborn Michigan, 1994 (Dearborn Conference) 

Association of State and Territorial Public Health Directors
Centers for Disease Control and Prevention
Michigan Department of Health 

Co-Sponsors of the Second National Conference on Serologic Diagnosis of Lyme Disease, Dearborn Michigan, 1994 (Dearborn Conference)

Food and Drug Administration
National Institutes of Health
Council of State and Territorial Epidemiologists
National Committee for Clinical Laboratory Standards

Let it be known that the worldwide Lyme disease/Borrelia-infected community has no need of or dependence upon the misinformation related to Lyme disease disseminated by these entities and individuals and shall henceforth shun any and all guidelines, reports, journal publications, articles, letters, comments, announcements, press releases and misinformation campaigns, etc. written and/or disseminated by such entities and individuals, that do not afford the God-given right to healthcare that Lyme disease/Borrelia-infected patients and their treating physicians have the right to exercise.

The God-given right to receive and practice healthcare includes choices of alternative and conventional treatments, including long-term courses of antibiotics, decided upon by Lyme disease/Borrelia-infected patients and their treating physicians.

The history of these entities and individuals relating to Lyme disease is a history of repeated injuries and usurpations, all having in direct object the establishment of an absolute Medical Tyranny over Lyme disease/Borrelia-infected patients and their treating physicians.  When a long succession of abuses and usurpations continues unabated, it becomes the Moral Duty of the oppressed to throw off such Medical Tyranny and Oppression and the entities and individuals engaged in exercising unrighteous dominion over suffering and oppressed patients and treating physicians.

HISTORY

Borrelia burgdorferi (Bb), the bacterium that causes Lyme disease infection, was isolated in a biowarfare lab at National Institutes of Health (NIH) Rocky Mountain Laboratories, located in Hamilton, Montana and named after the Rocky Mountain Laboratories researcher who discovered it, Dr. Willy Burgdorfer. 

As chronicled by Michael Carroll in his book Lab 257, the Lyme disease epidemic broke out just a few miles from the Plum Island Animal Disease Center (PIADC), a biowarfare research facility.  The PIADC is currently run by the United  States Department of Agriculture (USDA) under direction from the U.S. Department of Homeland Security (DHS).  According to Carroll, outdoor tick experiments were performed at the PIADC, which is located just off the coast of Long Island -- where Lyme infection rates are among the highest in the U.S.

Lab 257 documents that in 1958, Nazi biowarfare scientist Dr. Erich Traub, who had worked under the direction of SS Reichsfuhrer Heinrich Himmler in the Nazi's biowarfare program (cover name: Cancer Research Program), was selected by the USDA to be the director of Plum Island Animal Disease Center.  Although Dr. Traub declined the position, thereby retaining his directorship position at Tubingen Laboratory in West Germany, he visited PIADC frequently.

Some of the above-named entities and individuals exercise their self-proclaimed Lyme expert status by working together in a coordinated effort against Lyme disease/Borrelia-infected patients worldwide, patients who have been diagnosed with chronic Lyme and Borrelia infections by their treating physicians.  We refer to this group of entities and individuals as the Lyme Medical Cartel. 

Some members of the Lyme Medical Cartel serve in the Epidemic Intelligence Service (EIS), a branch of the U.S. military, whose pay rate is determined by the Department of Defense.  These EIS service personnel work under the direction of the Public Health Service (PHS) and the Centers for Disease Control and Prevention (CDC). 

Despite their Tyranny in the form of diagnosis and treatment denial to suffering patients, several entities and individuals who are and are not named above, own patents related to the Borrelia burgdorferi pathogen itself and Bb products and are active in biowarfare laboratory research.  Several Lyme disease researchers/Epidemic Intelligence Service personnel have been appointed as Directors of Biowarfare Labs (Dr. Alan G. Barbour in California, Dr. Mark S. Klempner in Massachussetts, Dr. Duane J. Gubler in Hawaii).  Borrelia burgdorferi, the bacterium that causes Lyme disease, is currently being studied in several biowarfare laboratories across the United States. 

Due to the fact that Borrelia Burgdorferi has been listed first as a Level III and now as a Level II biowarfare agent by the U.S. government, we have come to the conclusion that Lyme disease/Borrelia may be used as such a disabling biowarfare agent.  This disabling biowarfare agent has somehow become an epidemic and the agencies authorized to follow up with such a biowarfare agent/attack are ignoring the significance and urgency of this situation.  Patients and their families are struggling in their pursuit of proper acknowledgment, diagnosis and treatment for such debilitating Level II biowarfare agent infection.  This results in an unconscionable delay in treatment and irreversible damage to health and well-being. 

Per the CDC, Borrelia burgdorferi, the bacterium that causes Lyme disease, is transmitted by ticks, mosquitoes, and fleas.  In addition, the U.S. Armed Forces Pest Management Board has stated that horseflies carry the bacterium.  Physicians report transmission from mites, as well.

http://www.cdc.gov/media/pressrel/2007/r070614.htm

To prove our claims of Tyranny and Oppression, let Facts be submitted to the world regarding the entities and individuals named above, collectively and/or individually:

 
● The IDSA and its authors/representatives have written, published and promoted Practice Guidelines that deny the existence of chronic Lyme (Borrelia burgdorferi) infection, despite the authors’ own published scientific research that demonstrates such chronic Lyme infection exists -- even after an IDSA-recommended course of antibiotic therapy. 

This is an abstract from a published article co-written by Allen C. Steere, one of the authors of the 2000 and 2006 IDSA Lyme Disease Practice Guidelines, in the New England Journal of Medicine, Nov 22; 323(21):1438-44, which refers to a study of Borrelia burgdorferi: 

“These chronic neurologic abnormalities began months to years after the onset of infection, sometimes after long periods of latency, as in neurosyphilis…The typical response of our patients to antibiotic therapy supports the role of spirochetal infection in the pathogenesis of each of the syndromes described here…The likely reason for relapse is failure to eradicate the spirochete…This last article is one of many studies that show continuing symptoms are most likely due to persistence of the spirochete.”

The following is from another published article by Allen C. Steere:  

Steere, AC., Musculoskeletal manifestations of Lyme disease.  American Journal of Medicine, 1995, 88:4A-44S-51S. 

“…a 1-month course of oral antibiotics may not always eradicate viable spirochetes.”

From Raymond J. Dattwyler, another author of the 2000 and 2006 IDSA Lyme Disease Practice Guidelines:

Dattwyler, RJ., et al., Seronegative Lyme disease.  Dissociation of specific T-and B-lymphocyte responses to Borrelia burgdorferi.  New England Journal of Medicine, 1988, 319(22):1441-6. 

“We studied 17 patients who had presented with acute Lyme disease and received prompt treatment with oral antibiotics, but in whom chronic Lyme disease subsequently developed.”

The following research published in 1993 in the Journal of Infectious Diseases by Dr. Mark Klempner, a 2006 IDSA Lyme Disease Practice Guideline author and biowarfare laboratory director, also demonstrated the ability of Bb sequestration inside fibroblasts.

 “…We have demonstrated the presence of intracellular B. burgdorferi within HF (human fibroblasts) using laser scanning confocal microscopy…The observation of viable spirochetes within fibroblasts coupled to protection of B burgdorferi from extracellular microbicidal antibiotics by fibroblasts [19] suggests that B. burgdorferi may be among the small number of bacteria that can cause chronic infection by localizing within host cells where they remain sequestered from some antimicrobial agents and the host humoral immune response.”

● The IDSA and its authors/representatives have written, published and promoted Practice Guidelines that serve to delay diagnosis and prevent the majority of patients from receiving treatment for Lyme disease (Borrelia burgdorferi infection) immediately following a tick bite. 

http://www.journals.uchicago.edu/doi/full/10.1086/508667?cookieSet=
 

● Like Borrelia pathogens on a laboratory slide, the IDSA and its Lyme Disease Practice Guideline authors were viewed under a microscope in an investigation conducted by Connecticut Attorney General Richard Blumenthal.  Significantly, the IDSA signed an Agreement with the Attorney General, thus agreeing to an independent review of their Lyme disease Practice Guidelines.  Additionally, results of the investigation revealed the following conflicts of interest and errors committed by the IDSA.

http://www.leaparizona.com/ctagpressrelease.htm

● The AAN has sacrificed its credibility by allowing three members of the Lyme Medical Cartel, Dr. Gary P. Wormser, Dr. Eugene D. Shapiro and Dr. John J. Halperin, to virtually copy and paste the IDSA Lyme Disease Practice Guidelines into the AAN's Practice Guidelines for Lyme Disease.  The AAN merely renamed the biased IDSA Practice Guideline package by slapping its name over the IDSA label.  This groveling action exhibits the spineless nature of the AAN and its Lyme Disease Practice Guideline authors.  Through its endorsement of these copycat guidelines, the AAN has allowed itself to be led straight into the quicksand that is rapidly suffocating the Lyme Medical Cartel. 

Excerpt from Connecticut Attorney General Richard Blumenthal's May 1, 2008 Press Release referring to the AAN:

"The IDSA portrayed another medical association's Lyme disease guidelines as corroborating its own when it knew that the two panels shared several authors, including the chairmen of both groups, and were working on guidelines at the same time. In allowing its panelists to serve on both groups at the same time, IDSA violated its own conflicts of interest policy."

● A number of the above-named entities and individuals, collectively, at the Dearborn Conference in 1994, conspired in the removal of specific testing factors from serological testing criteria, thereby facilitating the development and marketing of testing products and vaccines and the financial gains derived from the sale of such lucrative products.  Such conspiratorial actions have prevented many patients from testing positive on such marketed Lyme disease test kits, thus sentencing false-negative infected patients to
 

with little chance of diagnosis and treatment until years later, after the bacteria have replicated and invaded the patients' neurological, musculoskeletal and cardiac systems. 

● Some of the members of the Lyme Medical Cartel have found it convenient to repeatedly testify against Lyme-treating, patient-friendly physicians during medical board prosecutions that mimic witch-hunt trials of old.  Such persecutory trials result in the loss of physicians’ licenses, practices and life savings.  Such prosecutions also result in sick and dying patients left without a physician to provide treatment for them and with no place to turn for healthcare. 

● The CDC has demonstrated its foreknowledge of such medical board prosecutions as demonstrated by a memorandum dated November 5, 1993 from Dr. Mary Grace Stobierski of the Disease Surveillance Section of the Michigan Department of Public Health to CDC Ft. Collins Epidemic Intelligence Service Officer Dr. David T. Dennis.  This memo was obtained through a Freedom of Information request.

"This press release concerns a physician being investigated for inappropriate treatment of Lyme disease.  You may recall that we discussed this matter a few weeks ago."

● Despite the antitrust investigation and findings of misconduct by the IDSA and its Lyme Disease Practice Guideline authors, along with the blatant contradictions between the IDSA Practice Guidelines and the authors' research, the CDC continues to breach its medical duty to the world by failing to provide Informed Consent to physicians and patients who look to the CDC website for information on diagnosis and treatment for Lyme disease.  The CDC is breaching its public duty by posting only the IDSA Practice Guidelines on its website, and dogmatically refuses to also post published Treatment Guidelines from the International Lyme and Associated Diseases Society (ILADS).  Despite the conflicts of interests revealed during the IDSA investigation, the CDC has made the following statement:

"Why CDC links to the IDSA guidelines

CDC provides a link to the IDSA guidelines as a service to clinicians.  CDC staff have reviewed the agreement signed by IDSA and the Connecticut Attorney General's Office.  The agreement does not call for revision of the IDSA guidelines, nor does it identify any inaccuracies or deficiencies in the guideline's conclusions or recommendations.  CDC believes that the IDSA guidelines continue to represent the best available synthesis of the medical literature on diagnosis and treatment of Lyme disease."
 

● Clinicians are not afforded the opportunity to make an informed choice of treatment with their patients due to the CDC's continued breach of public duty.  The CDC states that it "believes" the IDSA Lyme Disease Practice Guidelines  "represent the best available synthesis of the medical literature".  Obviously, the CDC has failed to present research performed by its own researchers, in which it was proven, once again, that Bb is an intracellular parasite that invades cells and evades the host immune system.
 

Excerpt from Invasion of Human Neuronal and Glial Cells by an Infectious Strain of Borrelia Burgdorferi by Jill A. Livengood and Robert D. Gilmore, Jr., Centers for Disease Control and Prevention, Division of Vector-borne Infectious Diseases, 3150 Rampart Road, CSU Foothills Campus, Fort Collins, CO 80522
 

"Human infection by Borrelia burgdorferi, the etiological agent for Lyme disease, can result in serious acute and late-term disorders including neuroborreliosis, a degenerative condition of the peripheral and central nervous systems."

"Invasion of neural cells by B. burgdorferi provides a putative mechanism for the organism to avoid the host's immune response while potentially causing functional damage to neural cells during infection of the CNS."  (Central Nervous System)

http://www.leaparizona.com/Invasion_of_Human_neuronal_and_Glial_cells_by_Borrelia.pdf

● The ILADS Guidelines are preferred and utilized by Lyme-treating physicians and patients worldwide.

http://www.guideline.gov/summary/summary.aspx?doc_id=4836&nbr=003481&string=lyme+AND+disease
 

● The CDC's exclusion of medical research that proves the existence of chronic Lyme infection and its continual endorsement of the IDSA Practice Guidelines that are skewed to control Lyme disease and prevent diagnosis and treatment, proves that the CDC is living up to its name by CONTROLLING diseases and PREVENTING treatment.

● The CDC published research in 2006 in which the researchers stated,

"Our results indicate that it is possible to acquire B. burgdorferi infection via transfused blood in a mouse model of Lyme borreliosis." 

● This means that it may be possible to become infected with Lyme disease through blood received from a blood transfusion.  We believe that the blood supply is not being checked adequately to ensure that blood transfusion recipients are safe from acquiring Borrelia burgdorferi (Lyme disease) infection.

● Members of the Lyme Medical Cartel make statements to the media such as this statement from Lyme Medical Cartel member Dr. Eugene Shapiro of Yale University in a July 8, 2008 article in The News Times:   

"Chronic Lyme disease doesn't exist,'' he said. "It's not these people don't have problems; it's not that I don't have compassion for them. But Lyme disease isn't the cause of their problems.''
 

● Statements such as these constitute an erroneous “diagnosis from afar” of a large, worldwide chronic Lyme/Borrelia patient population by physicians who have never examined such patients nor reviewed their medical records.  Dr. Shapiro’s distant diagnosis of this growing group of chronic Lyme/Borrelia sufferers demonstrates the Lyme Medical Cartel’s inappropriate practice of medicine on patients.  Such irresponsible insinuations may be compared to stating that all patients suffering from cancer don't really have cancer -- they have some other disease -- and because their treatment is  significantly harsh, treatment should be withheld from them until death ensues.  This would not be considered acceptable medical care for cancer patients -- Lyme/Borrelia-infected patients should not be expected to endure such inhumane denial of difficult long-term treatment either.

● The NIH has repeatedly granted millions of dollars in research funds to members of the Lyme Medical Cartel, including the CDC, who abuse their prominent positions by disseminating misinformation about Lyme disease to the public, thereby showing their disregard for the well-being of those seeking diagnosis and treatment for chronic Lyme/Borrelia infections.  These Lyme Medical Cartel grant recipients focus their research on acute Borrelia burgdorferi infection and vaccine development, and fail to perform patient-centered research on chronic Bb infection, stating that such chronic Bb infection does not exist, despite their own previously-published research that has demonstrated persistent, intracellular Borrelia burgdorferi infection post early antibiotic treatment. 

● The FDA approved a vaccine for Lyme disease called Lymerix, developed by Smith Kline Beecham pharmaceutical company.  During the approval process, it was disclosed that the Lymerix vaccine could cause Lyme arthritis in a subset of the recipients of the vaccine, yet the FDA approved it despite this healthcare risk.  Lymerix did indeed cause many cases of Lyme arthritis in previously-healthy vaccine recipients that resulted in failed health, numerous lawsuits and the subsequent removal of Lymerix from the market.  Some members of the Lyme Medical Cartel participated in the approval process.

● In 1997, Yale University patented a flagellin-based method for detection of Lyme disease that was based upon band 41kDa.  Yale claimed in the patent that the method of detection was "highly specific and highly sensitive"; yet to date, Lyme disease patients are not able to utilize this test to assist with their diagnoses.  The method is not being utilized for the benefit of patients.  Instead, patients and physicians are forced to test positive through an inaccurate screening test.  This inaccurate screening test, an ELISA, must be positive prior to subsequent testing by Western blot.  We see no benefit to patients through the use of this two-tiered testing system, especially since the ELISA screening test fails to turn up positive in approximately 50% of patients.  The two-tiered testing protocol forced upon us by the CDC and the other entities that conspired at the Dearborn Conference results in numerous patients left without any diagnosis or treatment for years at a time. 

Excerpt from U.S. Patent No. 5,618,533:

"Thus, a flagellin polypeptide comprising an immunodominant region corresponding to fragment 41G is highly specific and highly sensitive as well." (emphasis added)

● Many infectious disease physicians tell patients that they do not have Lyme/Borrelia infections.  These doctors tell patients that they have syphilis or rheumatoid arthritis instead, due to cross-reactivity.  These physicians should utilize the published research noted below by 2000 and 2006 IDSA Lyme disease Practice Guideline author/Medical Cartel Member, Dr. Allen C. Steere, and cease from using cross-reactivity as an excuse to deny Lyme/Borrelia diagnosis and treatment. 

Former Yale employee, Epidemic Intelligence Service Officer and Lyme Medical Cartel member, Dr. Allen C. Steere, co-authored the following article entitled

Antigens of Borrella burgdorferi Recognized during Lyme Disease 

“Furthermore, in this study, IgM antibodies to the 41-kD polypeptide were usually apparent by immunoblots before IgM titers were elevated by the current ELISA (12). Although antibodies reactive against this antigen may be present in patients with relapsing fever or syphilis (1 1,14), these diseases can be distinguished clinically from Lyme disease and therefore should not cause diagnostic confusion. The binding of this antigen by IgM from rheumatic disease controls was typically very weak and could potentially be blocked to avoid false-positive results in this group of patients.”   (emphasis added)

● A number of insurance companies utilize the biased IDSA Practice Guidelines to unscientifically deny the existence of chronic Lyme disease infection and to inhumanely deny long-term treatment to patients, thus denying patients and their treating physicians the God-given right to their choice of health care.  This forces patients into paying for long-term antibiotic treatment themselves.  In addition, patients sometimes need to travel out-of-state to obtain healthcare from Lyme-treating physicians.  This causes additional stress and undue hardship upon extremely ill people, most of whom have lost their jobs because of this chronic illness.  The result -- patients lose their health, careers, savings, homes, and due to the stress involved, sometimes their marriages and families.

●  Kaiser Permanente, a major insurance company, works with New York Medical College, which employs at least three members of the Lyme Medical Cartel.  We express our concern for the quality of information and research disseminated by Kaiser Permanente through New York Medical College and its employees/Lyme Medical Cartel members.

●  The majority of doctors who specialize in Infectious Disease parrot the mantra from the IDSA that chronic Lyme infection does not exist.  Their pre-scripted responses and references to not "believing" in chronic Lyme infection demonstrate their lack of knowledge and study of published research and a failed ability to think independently.  This large cult of infectious disease physicians acts like a herd of sheep that blindly follows its IDSA shepherd straight off the cliff into the abyss.  This is evident in the examples below as quoted from questionnaires completed by infectious disease physicians:

"I don't believe chronic Lyme exists."

"I follow the IDSA guidelines on the diagnosis and treatment of Lymes disease."

"I am not convinced such an entity exists after appropriate treatment.  Consensus of opinion is that extended Rx is of no benefit and may be harmful."

"Based on Infectious Disease Society of America's Practice Guidelines, no antibiotics recommended for "chronic" Lyme disease."

Such examples of patient neglect were also investigated and revealed by Connecticut Attorney General Richard Blumenthal in his May 1, 2008 press release:

●  The IDSA herd of blind sheep is also guilty of psychiatric abuse of Lyme/Borrelia-infected patients by making misleading psychiatric remarks and diagnoses.  The failure of these blind practitioners to understand that Borrelia burgdorferi does indeed cause psychiatric manifestations in Lyme disease/Borrelia-infected patients, constitutes negligent disregard for the lives of desperately-ill people.  The denial of diagnosis and treatment is a manipulative act of rejection.  Such despicable psychiatric abuse has caused already-depressed patients suffering from physiological depression or another psychiatric manifestation to reach the end point of committing suicide.  This act of rejection is an inexcusable crime made by doctors who tell Lyme/Borrelia-infected patients, "It's all in your head.  You're imagining your symptoms.  All you need is a hobby or job."  If these insensitive physicians would just provide antibiotic treatment to these patients, instead of insulting and rejecting them, the patients could recover from their depression through eradication of the cause -- infection of the brain by Borrelia pathogens.

http://www.mentalhealthandillness.com/Articles/AllInYourHead.htm

The ONGOING Lyme Disease Study

We believe that the lack of diagnosis and treatment of Lyme disease/Borrelia-infected patient victims may be related to epidemiological studies as to how Lyme disease ravages the bodies of "untreated  controls", as was done by the Public Health Service (PHS) in their infamous Tuskegee Study of Syphilis.  Both syphilis and Lyme disease are caused by similar spirochete bacteriums, with Borrelia burgdorferi (Lyme disease) appearing to be the more virulent pathogen.  Both diseases mimic each other and also mimic other infectious diseases caused by spirochetal pathogens . 

From The Tuskegee Timeline on CDC website:

"1936  Major paper published.  Study criticized because it is not known if men are being treated.  Local physicians asked to assist and asked not to treat men.  It was also decided to follow the men until death.

1969  CDC reaffirms need for study and gains local medical societies' support (AMA and NMA chapters officially support continuation of study.)"

http://www.cdc.gov/tuskegee/timeline.htm
 

Such a study could assist in developing a vaccine against a pathogen that is categorized as a Level II biowarfare agent by the United States government.  We believe that this may be the reason why a number of members of the Lyme Medical Cartel include Epidemic Intelligence Service Officers employed by the U.S. Military Public Health Service and Centers for Disease Control and Prevention.  The Lyme Medical Cartel members are responsible for the lack of diagnosis and treatment of patients by imposing disastrous treatment guidelines, such as those issued by the IDSA and AAN, which facilitate the ongoing study of Lyme disease in the population. 

We wish it to be known that Lyme disease and other Borrelia infections are of epidemic proportions throughout the United States and Europe.  Lyme/Borrelia infections are oftentimes misdiagnosed as multiple sclerosis, ALS, Parkinson's, autism, fibromyalgia, chronic fatigue syndrome, lupus and rheumatoid arthritis.  Research and patient experience has proven that Bb can result in chronic inflammatory and autoimmune disorders, certain lymphoma cancers, disability, miscarriages, stillbirths and death.

http://www.lymememorial.org/In_Memory_Of.htm

http://bloodjournal.hematologylibrary.org/cgi/content/abstract/111/12/5524

Due to the similarities between the Tuskegee Study of Syphilis and the lack of diagnosis and treatment for Lyme disease/Borrelia-infected patients being experienced worldwide, we expect investigational hearings be commenced by federal and/or state elected governmental representatives to make public the iniquitous circumstances surrounding the thirty-plus-year, ongoing denial of diagnosis and treatment.  Such hearings could thereby shed light on what we believe is the Lyme Disease/Borrelia Study, a modern-day Tuskegee-type experiment, which began just as the original Tuskegee Study was publicly exposed and terminated.  Such investigational hearings may determine the parties who are responsible for these outrageous Lyme Crymes and hold the guilty parties accountable for their negligent actions. 

Throughout these many years, in every stage of these Oppressions, petitions for redress have been made to these entities and individuals in the most humble terms.  We report that these petitions have fallen upon deaf ears and callous hearts and have been answered only by repeated injury. 

We, therefore, on behalf of the worldwide Lyme disease/Borrelia-infected community, appealing to the Supreme Judge of the World for Justice, Light and Truth, solemnly execute this Lyme Disease Medical Declaration of Independence from the Medical Tyranny and Oppression wrought upon us by the entities and individuals named herein.
 

Please see
www.lymecryme.com

for additional evidence of
Corruption, Tyranny and Oppression.

August 15, 2008

© No part of this document may be altered.
Send Inquiries to:  lymecrusader@yahoo.com

 

SIGNATORIES 

Arizona 

Michael Cepuch
State Representative
Arizona Agriculture Defense Coalition
www.arizonaskywatch.com

Bridget Conroy-Cepuch
State Representative
Arizona Agriculture Defense Coalition
www.arizonaskywatch.com

Tina J. Garcia
Lyme Education Awareness Program, L.E.A.P. Arizona
www.leaparizona.com

Connecticut

Randy Sykes
The Greater Hartford Lyme Disease Support & Action Group
www.ctlymedisease.org
www.lymecryme.org

Marjorie Tietjen
Lyme Patient and Advocate

Illinois

Dottie L. Heffron
Illinois Lyme Disease Network
www.illinoislyme.com

Linda Sauer
Illinois Lyme Disease Network
www.illinoislyme.com

North Carolina

Jerry Leonard
www.winstonsmith.net

Mr. and Mrs. T. Vogan
Concerned U.S. Citizens

South Carolina

Kathleen Liporace
Greenville Lyme Advocacy & Support Group
SC Lyme Advocacy

Washington

Miguel Perez-Lizano
www.kaiserpapers.org

Click Here to View
SUPPORTING SIGNATORIES